Sisram Medical Ltd. to Hold FY 2024 Financial Results Conference Call on March 20 at 800 a.m. ET
10.09.24
Sirsram Medical announces NMPA approval for DAXXIFY®, Marking the introduction of the world’s first and only peptide-powered botulinum toxin product to Mainland China
21.08.24
Sisram Medical Announces First-Half 2024 Financial Results
15.08.24
Sisram Medical Ltd. to Hold H1 2024 Financial Results Conference Call on August 22 at 830 a.m. ET.
20.03.24
Sisram Medical Announces 2023 Annual Results
14.03.24
Sisram Medical to Hold FY2023 Financial Results Conference Call on March 21
14.11.23
Alma, a Sisram Medical Company, Reinforces its APAC Leadership with the Establishment of a New Venture in Japan
23.08.23
Sisram Medical Announces H1 2023 Financial Results
17.08.23
Sisram Medical Ltd. to Hold H1 2023 Financial Results Conference Call on August 24 at 8:00 a.m. ET
